NCT03384836 2025-07-02
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 1/2 Suspended
Clinical Trials
5 trialsNCT03152786 2025-02-17
Propranolol Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Wake Forest University Health Sciences
Phase 2 Terminated
NCT01847001 2021-09-10
Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Columbia University
Phase 2 Completed
NCT02420223 2021-06-07
Study of Propranolol to Decrease Gene Expression of Stress-Mediated Beta-Adrenergic Pathways in HCT Recipients
Medical College of Wisconsin
Phase 2 Completed
NCT01504126 2019-08-29
Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Completed